Acute fasting diminishes the circadian rhythm of biochemical markers of bone resorption
|
|
- Rosemary Doyle
- 5 years ago
- Views:
Transcription
1 European Journal of Endocrinology (1999) ISSN Acute fasting diminishes the circadian rhythm of biochemical markers of bone resorption A Schlemmer and C Hassager Center for Clinical and Basic Research, Ballerup Byvej 222, DK-2750 Ballerup, Denmark (Correspondence should be addressed to A Schlemmer) Abstract Objective: Biochemical markers of bone turnover exhibit circadian rhythms with the peak during the night/early morning and the nadir in the late afternoon. The nocturnal increase in bone resorption could theoretically be caused by the absence of food consumption which brings about a decrease in net calcium absorption and an increase in parathyroid hormone (PTH), followed by increased bone resorption in response to the body s demand for calcium. The aim of the present study was to assess the influence of a 33-h fast on the circadian variation in biochemical markers of bone turnover. Design: Eleven healthy premenopausal women (age: 24 5 years) participated in a randomised, crossover study consisting of two periods: either 33 h of fasting (fasting) followed 1 week later by a 33-h period with regular meals eaten at h, h and h (control) or vice versa. Methods: Urinary CrossLaps (U-CL/Cr) corrected with creatinine, as a marker of bone resorption; serum osteocalcin (soc) as a marker of bone formation; serum intact PTH (ipth); serum phosphate; and serum calcium corrected with albumin. Results: Both the fasting and the control periods showed a significant circadian rhythm in U-CL/Cr (P < 0.001), but the decrease was significantly less pronounced in the morning hours during the fasting period. Fasting resulted in a significant decrease in serum ipth (throughout the study period) as compared with the control period (P < ). No change was observed in soc by fasting. Conclusion: Food consumption has a small influence on the circadian variation in bone resorption, independent of PTH. The fall in ipth during fasting may be secondary to an increased bone resorption produced by fasting. European Journal of Endocrinology Introduction A well-known circadian variation with the peak during the night/early morning and the nadir late in the afternoon has been described in biochemical parameters of bone resorption such as the urinary excretion of pyridinium cross-links (1 4), urinary cross-linked N-telopeptide of type I collagen (NTx) (5), urinary CrossLaps (6) and serum carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen (7). A less pronounced circadian variation is also known in biochemical markers of bone formation, such as serum osteocalcin (soc) (4, 8) and serum procollagen type I carboxy-terminal propeptide (7, 9). Whereas the circadian variation in bone formation may be dependent on the circadian fluctuation in serum cortisol (10 12), the aetiology of the circadian variation in bone resorption remains unknown. Earlier studies have found the variation in bone resorption to be independent of age, menopausal status, posture (2), and the circadian fluctuations in serum cortisol (12). However, the influence of calcium is ambiguous. Suppression of intact parathyroid hormone (ipth) with a constant infusion of calcium did not influence the circadian pattern of the urinary Ntx (5), whereas the nocturnal peak in the urinary Ntx was suppressed by 1000 mg calcium administered at 2300 h for 14 days (13). A recent study demonstrated, in rats, that when solid food and liquid intake were divided into portions, the peak in bone resorption seen after food ingestion was blunted and the 24-h bone resorption decreased. After 30 days on this schedule an increase in bone mass was observed (14). Ebeling et al. (15) had previously shown that the total 24-h urinary excretion of pyridinium cross-links increased with 4 days of calcium deprivation (dietary calcium (230 mg/day) and treatment with a calciumbinding agent). Grinspoon et al. (16), however, failed to find any significant response in the 24-h urinary excretion of pyridinium cross-links with 4 days of fasting. Neither of these studies, however, was designed to examine the effect of fasting on the circadian rhythm 1999 Society of the European Journal of Endocrinology Online version via
2 EUROPEAN JOURNAL OF ENDOCRINOLOGY (1999) 140 Circadian rhythm in bone resorption, influenced by fasting 333 in biochemical markers of bone resorption. Theoretically, therefore, the nocturnal peak in bone resorption may be caused by the absence of food consumption, followed by an increased bone resorption in response to the body s demand for calcium. The aim of the present study was to investigate this hypothesis. Participants and methods Participants Eleven healthy premenopausal women (age: 24 5 years; height: cm; weight: 63 6 kg (mean 1 S.D.)) participated in a randomised, cross-over study consisting of two periods of either 33 h of fasting (water, coffee and tea permitted) followed 1 week later by a 33-h period with regular meals eaten at h, h and h or vice versa. Normal daytime activities and sleeping pattern were permitted. None of the women had known endocrine or renal disease, or were taking any medication at the time of the study. All the women fasted from 2300 h on the evening before the start of the two 24-h periods. The participants emptied their bladder at 0500 h in the morning, and urine was collected in 3-h aliquots starting at 0500 h until the following day at 0800 h. Blood samples were taken at 3-h intervals starting at 0800 h. The blood and urine samples were stored at ¹20 C until assayed. The research protocol was approved by the Ethical Committee of Copenhagen County (KA95114g). All the participants gave their informed consent, in accordance with the Helsinki II Declaration. Methods Urinary CrossLaps were measured by an ELISA assay based on an antiserum (rabbit) reaction with a sequence derived from type I collagen (EKAHDGGR). The average within-run and total coefficients of variation of the assay were 5.3% and 6.6% respectively (17). The results were then corrected with creatinine (Cr) and expressed as mg/mol creatinine. The soc was measured by a two-site enzymelinked immunosorbent assay (N-MID hosteocalcin; Osteometer BioTech A/S, Herlev, Denmark). The assay is based on two highly specific monoclonal antibodies against human osteocalcin, recognising the mid region (amino acids 20 43) and the N-terminal region (amino acids 1 19) respectively, and the assay thus detected intact osteocalcin (1 49) as well as the N-terminal mid fragment (1 43). The assay had a measuring range of mg/l and a detection limit of 2.0 mg/l. The intra- and interassay coefficients of variation were less than 7% (18). Serum ipth was measured by a commercially available IRMA (Coat-A-Count Intact PTH IRMA; Diagnostic Products Corporation, Los Angeles, CA, USA). The detection limit was 0.1 pmol/l and the intra-assay coefficient of variation was 6.0%. Serum calcium, serum phosphate, urinary creatinine, and serum albumin were measured by standard laboratory methods. Statistical analysis The results of the biochemical assays were analysed using the procedures of the SAS Institute (19). To obtain normality and homogeneity of variance, urinary Cross- Laps/Cr and soc were logarithmically transformed (log concentration) before analysis of the circadian rhythm. These serial measurements were analysed according to concepts described by Matthews et al. (20). The 24-h cyclical changes were calculated for each woman by multiple-regression analysis, with sine and cosine as independent variables (e.g. y = b1 sin (t)+b2 cos (t)+a, where t =2p time (h)/24). The coefficients (b1 and b2) to sine and cosine were then used as summary measures of the circadian variation and compared with zero by multiple analysis of variance (19). Student s paired t-test was used for comparison within groups. For visualising the effect of fasting, a delta value of urinary CrossLaps/Cr and soc is given as mean of control value fasting value for each individual at each time-point. Serum calcium was corrected by albumin (e.g. total Ca + 1.1(0.70¹serum albumin)). Results Figure 1 shows the 24-h fluctuation in the urinary excretion of CrossLaps/Cr and soc. A highly significant circadian variation in urinary CrossLaps/Cr was observed during both the fasting and the control period (P < 0.001). A significantly less pronounced decrease during the morning and afternoon hours (P < ) was observed in the fasting group as compared with the controls. soc showed a circadian rhythm during the control period (P<0.01) and the fasting period (P = 0.05). Fasting did not change the circadian pattern in soc significantly. Figure 2 shows the 24-h fluctuation in the urinary excretion of CrossLaps/3 h. The pattern of the curves was similar to the CrossLaps/Cr curves, with a significantly less pronounced decrease observed in the fasting period between 1100 and 1400 h (P < 0.01). One value was dismissed at the first time-point because of collection error. Figure 3 shows the 24-h fluctuation in serum ipth, serum calcium (corrected for albumin) and serum phosphate. Fasting significantly decreased (P < ) ipth and abolished the circadian rhythm in ipth. Albumin-corrected serum calcium was significantly higher during the daytime in the fasting period than in the control period. In serum phosphate no significant differences between the fasting and the control period was seen at any time-point.
3 334 A Schlemmer and C Hassager EUROPEAN JOURNAL OF ENDOCRINOLOGY (1999) 140 Figure 1 Mean values of the urinary (U) excretion of CrossLaps/Cr and serum (S) osteocalcin during the two 24-h periods (left-hand figures). Fasting is shown as solid circles and control as solid triangles. Mean delta value of urinary CrossLaps/Cr and soc is given as control value fasting value for each individual at each time-point (right-hand figures). Values are means S.E.M. *P< 0.05; **P < The mean (average of eight time-points) increased significantly in serum calcium (mmol/l) (corrected for albumin) ( vs ; P < 0.05) and decreased significantly in serum ipth ( vs pmol/l; P < 0.01) whereas no significant differences was observed in the urinary CrossLaps/Cr ( vs ng/mmol; not significant) or serum phosphate ( vs mmol/l; not significant). All values are given as control vs fasting. Discussion Food consumption alone cannot explain the circadian rhythm in the biochemical markers of bone resorption even though fasting significantly changes the circadian pattern. However, part of the circadian variation seen in healthy individuals is probably caused by food. The circadian variation in the biochemical markers of bone resorption seen in this study was more pronounced in the control period, when regular Figure 2 Mean value of the urinary (U) excretion of Crosslaps/3 h during the two 24-h periods. Fasting is shown as solid circles and control as solid triangles. Values are means S.E.M. **P< 0.01.
4 EUROPEAN JOURNAL OF ENDOCRINOLOGY (1999) 140 Circadian rhythm in bone resorption, influenced by fasting 335 Figure 3 Mean value of serum (S) ipth, serum calcium (S-Ca) (alb.corr., corrected for albumin) and serum (S) phosphate during the two 24-h periods. Fasting is shown as solid circles and control as solid triangles. Values are means S.E.M.*P <0:05; **P < 0:01; ***P < 0:001. meals were served, than in the fasting period. Urinary CrossLaps/Cr fell more significantly after food ingestion in the daytime, whereas the curves for the evening and the following night (when none of the participants were given any meals) were indistinguishable. This effect on urinary CrossLaps/Cr was not caused by an increase in PTH in order to maintain the serum calcium at an acceptable physiological level, because serum ipth actually fell and the circadian pattern was abolished, whereas serum calcium increased during fasting. It is more likely that a direct demineralisation took place during fasting, which increased serum calcium, followed by a decrease in serum ipth as the outcome. These changes may be mediated by the acidosis caused by fasting. An earlier study by Kocian & Brodan (21) demonstrated that short-term starvation of obese subjects induces metabolic acidosis and increased calciuria, resulting in a severe negative calcium balance. As most body calcium resides in bone mineral, the elevated urinary excretion of calcium is likely to originate from bone. Experimental studies with neonatal mouse calvariae cultured in medium with a reduced ph (an in vitro model of metabolic acidosis) have further shown that there is a net efflux of calcium from the bone during acute 3-h culture (22) and chronic culture (24 h or longer) (23, 24). Furthermore, Krieger et al. (25) demonstrated increased osteoclastic activity and decreased osteoblastic activity in an experimental model of metabolic acidosis. Hence the well-known circadian variation in bone resorption with the peak during the night could, theoretically, be caused in part by the nightly fast although the present study showed that this can only explain a small part of the circadian variation in bone resorption. In serum phosphate no significant difference was observed between the fasting and control period at any time-point, suggesting that the effect of fasting is mediated through calcium metabolism rather than phosphate. When the present study was planned there were no data in the literature regarding the influence of food intake on the circadian variation of bone resorption. We thus did not know whether a change in food intake would affect the overall circadian variation in bone resorption or whether it would have an acute effect just during daytime or no effect at all. The present study was therefore designed to have 80%
5 336 A Schlemmer and C Hassager EUROPEAN JOURNAL OF ENDOCRINOLOGY (1999) 140 power (at a 5% significance level) to detect an elimination of the circadian effect on urinary excretion of CrossLaps at a specific time-point. We found a significant effect of fasting only during the early day time which was not reflected in the 24-h urinary excretion of CrossLaps. We therefore believe that this finding needs to be confirmed before a final conclusion can be drawn regarding the magnitude of the effect of food intake on the circadian variation of bone resorption. We did not include the participants at a specific time in their menstrual cycle in this study. However the time-span between the two study periods is short (1 week) and the study was performed as a randomised, cross-over study for which reason we do not believe that the fluctuations in hormones during the menstrual period has any influence on the results presented in this article. Serum ipth peaked at about 2000 h in our control period, whereas it usually occurs between 0200 and 0600 h (26 28). The participants were up in order to empty their bladder completely. This practice has no influence on the circadian variation in biochemical markers of bone resorption (2), but perhaps it affected the time at which serum PTH peaked. A shift in sleeping time is known to blunt the start of the rise in serum PTH (27), although the theoretical changes in sleeping pattern caused by the nightly awakening in this study are of less magnitude than in the study of Logue et al. (27). We and others have shown the circadian rhythm in bone resorption to be independent of sex steroids, posture (2), and fluctuations in cortisol (12) and PTH (5). The present acute fasting study provides the first evidence to explain parts of the changes in the circadian variation in biochemical markers of bone resorption. However, it explains only a small part, the greater part of the aetiology of the circadian rhythm in bone resorption still remains unsolved. Further studies are needed especially a longer period of fasting in order to assess whether the observed changes continue in the following days, and to establish which particular components of the food are able to induce a further decrease in the urinary excretion of CrossLaps. The latter is probably not caused by calcium intake, based on the response of serum PTH to fasting. In conclusion, we found that food consumption in the morning potentiates the morning/early afternoon decrease in the urinary excretion of CrossLaps, a new marker of bone resorption. This effect seems to be independent of PTH. Reference 1 Schlemmer A, Hassager C, Jensen SB & Christiansen C. Marked diurnal variation in urinary excretion of pyridinium crosslinks in premenopausal women. Journal of Clinical Endocrinology and Metabolism Schlemmer A, Hassager C, Pedersen BJ & Christiansen C. Posture, age, menopause, and osteopenia do not influence the circadian variation in the urinary excretion of pyridinium crosslinks. Journal of Bone and Mineral Research Eastell R, Calvo MS, Burritt MF, Offord KP, Russell RGG & Riggs BL. Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis. Journal of Clinical Endocrinology and Metabolism Eastell R, Simmons PS, Colwell A, Assiri AMA, Burritt MF, Russell RGG et al. Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: effects of growth and ageing. Clinical Science Ledger GA, Burritt MF, Kao PC, O Fallon WM, Riggs BL & Khosla S. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. Journal of Clinical Endocrinology and Metabolism Schlemmer A, Ravn P, Hassager C & Christiansen C. Morning or evening administration of nasal calcitonin? Effects on biochemical markers of bone turnover. Bone Hassager C, Risteli J, Risteli L, Jensen SB & Christiansen C. Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women. Journal of Bone and Mineral Research Nielsen HK, Brixen K & Mosekilde L. Diurnal rhythm and 24-hour integrated concentrations of serum osteocalcin in normals: influence of age, sex, season, and smoking habits. Calcified Tissue International Pedersen BJ, Schlemmer A, Rosenquist C, Hassager C & Christiansen C. Circadian rhythm in type I collagen formation in postmenopausal women with and without osteopenia. Osteoporosis International Nielsen HK, Brixen K, Kassem M, Charles P & Mosekilde L. Inhibition of the morning cortisol peak abolishes the expected morning decrease in serum osteocalcin in normal males: evidence of a controlling effect of serum cortisol on the circadian rhythm in serum osteocalcin. Journal of Clinical Endocrinology and Metabolism Nielsen HK, Charles P & Mosekilde L. The effect of single oral dose of prednisone on the circadian rhythm of serum osteocalcin in normal subjects. Journal of Clinical Endocrinology and Metabolism Schlemmer A, Hassager C, Alexandersen P, Fledelius C, Pedersen BJ, Kristensen JØ et al. The circadian variation in bone resorption is not related to serum cortisol. Bone Blumsohn A, Herrington K, Hannon RA, Shao P, Eyre DR & Eastell R. The effect of calcium supplementation on the circadian rhythm of bone resorption. Journal of Clinical Endocrinology and Metabolism Mühlbauer RC & Fleisch H. The diurnal rhythm of bone resorption in the rat. Effect of feeding habits and pharmacological inhibitors. Journal of Clinical Investigation Ebeling PR, Jones JD, Burritt MF, Duerson CR, Lane AW, Hassager C et al. Skeletal responsiveness to endogenous parathyroid hormone in postmenopausal osteoporosis. Journal of Clinical Endocrinology and Metabolism Grinspoon SK, Baum HBA, Kim V, Coggins C & Klibanski A. Decreased bone formation and increased mineral dissolution during acute fasting in young women. Journal of Clinical Endocrinology and Metabolism Bonde M, Qvist P, Fledelius C, Riis BJ & Christiansen C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clinical Chemistry Rosenquist C, Quist P, Bjarnason N & Christiansen C. Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clinical Chemistry
6 EUROPEAN JOURNAL OF ENDOCRINOLOGY (1999) 140 Circadian rhythm in bone resorption, influenced by fasting SAS Institute. SAS/STAT Guide for Personal Computers, ed. 6. Cary, NC: SAS Institute, Matthews JNS, Altman DG, Campbell MJ & Royston P. Analysis of serial measurements in medical research. British Medical Journal Kocian J & Brodan V. Simultaneous correction of Ca deficiency and acidosis in fasting obese patients as a prevention of bone demineralisation. Nutrition and Metabolism Bushinsky DA, Krieger NS, Geisser DI, Grossman EB & Coe FL. Effect of ph on bone calcium and proton fluxes in vitro. American Journal of Physiology (Renal Fluid Electrolyte Physiology 14) F204 F Bushinsky DA. Net calcium efflux from live bone during chronic metabolic, but not respiratory, acidosis. American Journal of Physiology (Renal Fluid Electrolyte Physiology 25) F836 F Chabala JM, Levi-Setti R & Bushinsky DA. Alteration in surface ion composition of cultured bone during metabolic, but not respiratory, acidosis. American Journal of Physiology (Renal Fluid Electrolyte Physiology 30) F76 F Krieger NS, Sessler NE & Bushinsky DA. Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro. American Journal of Physiology (Renal Fluid Electrolyte Physiology 31) F442 F Logue FC, Fraser WD, Gallacher SJ, Cameron DA, O Reilly DStJ, Beastall GH et al. The loss of circadian rhythm for intact parathyroid hormone and nephrogenous cyclic AMP in patients with primary hyperparathyroidism. Clinical Endocrinology Logue FC, Fraser WD, O Reilly DStJ, Christie J, Cameron DA, Wallace DC et al. Sleep shift dissociates the nocturnal peaks of parathyroid hormone (1 84), nephrogenous cyclic adenosine monophosphate, and prolactin in normal men. Journal of Clinical Endocrinology and Metabolism Fraser WD, Logue FC, Christie JP, Cameron DA, O Reilly DStJ & Beastall GH. Alteration of the circadian rhythm of intact parathyroid hormone following a 96-hour fast. Clinical Endocrinology Received 22 May 1998 Accepted 14 January 1999
European Journal of Endocrinology (1997) ISSN
European Journal of Endocrinology (1997) 137 167 171 ISSN 0804-4643 Change in C-terminal cross-linking domain of type I collagen in urine, a new marker of bone resorption, during and after gonadotropin-releasing
More informationCa, Mg metabolism, bone diseases. Tamás Kőszegi Pécs University, Department of Laboratory Medicine Pécs, Hungary
Ca, Mg metabolism, bone diseases Tamás Kőszegi Pécs University, Department of Laboratory Medicine Pécs, Hungary Calcium homeostasis Ca 1000g in adults 99% in bones (extracellular with Mg, P) Plasma/intracellular
More informationThe Role of the Laboratory in Metabolic Bone Disease
The Role of the Laboratory in Metabolic Bone Disease Howard Morris PhD, FAACB, FFSc(RCPA) President, IFCC Professor of Medical Sciences, University of South Australia, Clinical Scientist, SA Pathology
More informationResponse of several markers of bone collagen degradation to calcium supplementation in postmenopausal women with low calcium intake
Clinical Chemistry 44:7 1437 1442 (1998) Enzymes and Protein Markers Response of several markers of bone collagen degradation to calcium supplementation in postmenopausal women with low calcium intake
More informationDecreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing s syndrome
European Journal of Endocrinology (1999) 141 126 131 ISSN 0804-4643 CLINICAL STUDY Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing
More informationO steoarthritis (OA) and other arthritic diseases involving
332 EXTENDED REPORT Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass
More informationClinical Evaluation of the Elecsys -CrossLaps Serum Assay, a New Assay for Degradation Products of Type I Collagen C-Telopeptides
Clinical Chemistry 47:8 1410 1414 (2001) Enzymes and Protein Markers Clinical Evaluation of the Elecsys -CrossLaps Serum Assay, a New Assay for Degradation Products of Type I Collagen C-Telopeptides Reiko
More informationEuropean Journal of Endocrinology (2002) ISSN
European Journal of Endocrinology (2002) 146 635 642 ISSN 0804-4643 CLINICAL STUDY Diurnal rhythm of plasma 1,25-dihydroxyvitamin D and vitamin D-binding protein in postmenopausal women: relationship to
More informationElecsys bone marker panel. Optimal patient management starts in the laboratory
bone marker panel Optimal patient management starts in the laboratory Complete solution for osteoporosis The most complete bone metabolism panel on a single platform bone marker assays are important diagnostic
More informationClinician s Guide to Prevention and Treatment of Osteoporosis
Clinician s Guide to Prevention and Treatment of Osteoporosis Published: 15 August 2014 committee of the National Osteoporosis Foundation (NOF) Tipawan khiemsontia,md outline Basic pathophysiology screening
More informationAdditional Research is Needed to Determine the Effects of Soy Protein on Calcium Binding and Absorption NDFS 435 3/26/2015. Dr.
Additional Research is Needed to Determine the Effects of Soy Protein on Calcium Binding and Absorption NDFS 435 3/26/2015 Dr. Tessem Osteoporosis is a public health problem in all stages of life. Many
More informationIndex. B BMC. See Bone mineral content BMD. See Bone mineral density Bone anabolic impact, Bone mass acquisition
A Acid base balance dietary protein detrimental effects of, 19 Acid base balance bicarbonate effects, 176 in bone human studies, 174 mechanisms, 173 174 in muscle aging, 174 175 alkali supplementation
More informationThe Skeletal Response to Aging: There s No Bones About It!
The Skeletal Response to Aging: There s No Bones About It! April 7, 2001 Joseph E. Zerwekh, Ph.D. Interrelationship of Intestinal, Skeletal, and Renal Systems to the Overall Maintenance of Normal Calcium
More informationEndocrine Regulation of Calcium and Phosphate Metabolism
Endocrine Regulation of Calcium and Phosphate Metabolism Huiping Wang ( 王会平 ), PhD Department of Physiology Rm C516, Block C, Research Building, School of Medicine Tel: 88208252 Email: wanghuiping@zju.edu.cn
More informationBone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome
Bone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome Thomas et al. Nutrition Journal (2015) 14:99 DOI 10.1186/s12937-015-0092-2 RESEARCH Open Access Acute effect of a supplemented
More informationClinical Utility of Biochemical Markers of Bone Remodeling
Clinical Chemistry 45:8(B) 1359 1368 (1999) Beckman Conference Clinical Utility of Biochemical Markers of Bone Remodeling Nelson B. Watts Remodeling is essential for bone health. It begins with resorption
More informationproduction in healthy man Introduction
Journal of Internal Medicine 1997; 241: 143 150 Effects of short-term insulin-like growth factor-i or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1,25 dihydroxyvitamin production
More informationEthnic differences in calcium, phosphate and bone metabolism
(2014), 73, 340 351 The Authors 2014 First published online 12 March 2014. The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons
More informationBone Turnover Markers for the Diagnosis and Management of Osteoporosis and Diseases Associated with High Bone Turnover. Original Policy Date
MP 2.04.10 Bone Turnover Markers for the Diagnosis and Management of Osteoporosis and Diseases Associated with High Bone Turnover Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013
More informationAnnie WC Kung, Keith DK Luk, LW Chu, and Peter KY Chiu
Age-related osteoporosis in Chinese: an evaluation of the response of intestinal calcium absorption and calcitropic hormones to dietary calcium deprivation 1 3 Annie WC Kung, Keith DK Luk, LW Chu, and
More informationMonitoring hormone replacement therapy by biochemical markers of bone metabolism in menopausal women
727 REVIEW Monitoring hormone replacement therapy by biochemical markers of bone metabolism in menopausal women E Dogan, C Posaci... Biochemical markers of bone metabolism are divided into two groups:
More informationEuropean Journal of Endocrinology (1998) ISSN
European Journal of Endocrinology (1998) 139 276 283 ISSN 0804-4643 The importance of body weight history in the occurrence and recovery of osteoporosis in patients with anorexia nervosa: evaluation by
More informationDiagnosis and Treatment of Osteoporosis. Department of Endocrinology and Metabolism Ajou University School of Medicine.
Diagnosis and Treatment of Osteoporosis Department of Endocrinology and Metabolism Ajou University School of Medicine Yoon-Sok CHUNG WCIM, COEX, Seoul, 27Oct2014 Case 1 71-year old woman Back pain Emergency
More informationRole of Gastrointestinal Hormones in Postprandial Reduction of Bone Resorption ABSTRACT
JOURNAL OF BONE AND MINERAL RESEARCH Volume 18, Number 12, 2003 2003 American Society for Bone and Mineral Research Role of Gastrointestinal Hormones in Postprandial Reduction of Bone Resorption DENNIS
More informationUniversity of Medicine and Pharmacy Craiova. Faculty of Medicine. PhD THESIS ABSTRACT
University of Medicine and Pharmacy Craiova Faculty of Medicine PhD THESIS ABSTRACT STUDY OF THE CHANGES IN BONE MASS AND BONE METABOLISM MARKERS IN THYROTOXIC OSTEOPOROSIS. THERAPEUTIC IMPLICATIONS. Scientific
More information9/26/2016. The Impact of Dietary Protein on the Musculoskeletal System. Research in dietary protein, musculoskeletal health and calcium economy
The Impact of Dietary Protein on the Musculoskeletal System Outline A. The musculoskeletal system and associated disorders Jessica D Bihuniak, PhD, RD Assistant Professor of Clinical Nutrition Department
More informationProtocol GTC : A Randomized, Open Label, Parallel Design Study of Sevelamer Hydrochloride (Renagel ) in Chronic Kidney Disease Patients.
Protocol GTC-68-208: A Randomized, Open Label, Parallel Design Study of Sevelamer Hydrochloride (Renagel ) in Chronic Kidney Disease Patients. These results are supplied for informational purposes only.
More informationAcid-base imbalance and the skeleton
Eur J Nutr 40 : 238 244 (2001) ORIGINAL CONTRIBUTION David A. Bushinsky Received: 13 September 2001 Accepted: 20 September 2001 David A. Bushinsky, M. D. ( ) Professor of Medicine and of Pharmacology and
More informationCollagen Crosslinks, Any Method
190.19 - Collagen Crosslinks, Any Method Collagen crosslinks, part of the matrix of bone upon which bone mineral is deposited, are biochemical markers the excretion of which provides a quantitative measurement
More informationImmunodiagnostic Systems
Immunodiagnostic Systems Manual Immunoassay Product Menu www.idsplc.com Vitamin D 25-Hydroxy Vitamin D EIA Enzymeimmunoassay for the quantitative IVD AC-57F1 96 Wells determination of 25-hydroxyvitamin
More informationCortisol Inhibits Acid-Induced Bone Resorption In Vitro
J Am Soc Nephrol 13: 2534 2539, 2002 Cortisol Inhibits Acid-Induced Bone Resorption In Vitro NANCY S. KRIEGER, KEVIN K. FRICK, and DAVID A. BUSHINSKY Department of Medicine, Nephrology Unit, University
More informationIFCC Professional Scientific Exchange Programme (PSEP) Report:
IFCC Professional Scientific Exchange Programme (PSEP) Report: BIOCHEMICAL MARKERS OF BONE TURNOVER ON WELL-CONTROLLED POSTMENOPAUSAL WOMEN WITH TYPE 2 DIABETES MELLITUS. Osteopenia is recognized in diabetic
More informationDeterminants of Reduced Bone Mineral Density and Increased Bone Turnover after Kidney Transplantation: Cross-sectional Study
398 41(4):396-400,2000 CLINICAL SCIENCES Determinants of Reduced Bone Mineral Density and Increased Bone Turnover after Kidney Transplantation: Cross-sectional Study Vesna Kušec, Ru ica Šmalcelj 1, Selma
More informationPage: 1 of 12. Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated With High Bone Turnover
Last Review Status/Date: March 2017 Page: 1 of 12 Management of Osteoporosis and Diseases Description Bone turnover markers are biochemical markers of either bone formation or bone resorption. Commercially
More informationZinc Intake and Biochemical Markers of Bone Turnover in Type 1 Diabetes
Diabetes Care Publish Ahead of Print, published online September 22, 2008 Zinc and bone markers Zinc Intake and Biochemical Markers of Bone Turnover in Type 1 Diabetes Raelene E. Maser, PhD 1,2; John N.
More informationPART FOUR. Metabolism and Nutrition
PART FOUR Metabolism and Nutrition Advances in Peritoneal Dialysis, Vol. 21, 2005 Maria Mesquita, 1 Eric Wittersheim, 2 Anne Demulder, 2 Max Dratwa, 1 Pierre Bergmann 3 Bone Cytokines and Renal Osteodystrophy
More informationPage: 1 of 12. Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated With High Bone Turnover
Last Review Status/Date: December 2014 Page: 1 of 12 Management of Osteoporosis and Diseases Description Bone turnover markers are biochemical markers of either bone formation or bone resorption. Commercially
More informationDavid Bruyette, DVM, DACVIM
VCAwestlaspecialty.com David Bruyette, DVM, DACVIM Disorders of calcium metabolism are common endocrine disorders in both dogs and cats. In this article we present a logical diagnostic approach to patients
More informationBone and Mineral. Comprehensive Menu for the Management of Bone and Mineral Related Diseases
Bone and Mineral Comprehensive Menu for the Management of Bone and Mineral Related Diseases Innovation to Assist in Clinical Diagnosis and Treatment DiaSorin offers a specialty line of Bone and Mineral
More informationMelatonin and Growth Hormone Deficiency: A Contribution to the Evaluation of Neuroendocrine Disorders
Melatonin and Growth Hormone Deficiency: A Contribution to the Evaluation of Neuroendocrine Disorders Fideleff G., Suárez M., Boquete HR, Azaretzky M., Sobrado P., Brunetto O*, Fideleff HL Endocrinology
More informationAdrenal Stress Profile (Saliva)
Adrenal Stress Profile (Saliva) Ireland Cortisol Levels Sample 1 Post Awakening Sample 2 (+ 4-5 Hours) Sample 3 (+ 4-5 Hours) Sample 4 (Prior to Sleep) 11.42 2.10 1.60 0.47 Sum of Cortisol 15.590 DHEA
More informationEvaluation of a Bead-based Enzyme Immunoassay for the Rapid Detection of Osteocalcin in Human Serum
Clinical Chemistry 46:2 252 257 (2000) Endocrinology and Metabolism Evaluation of a Bead-based Enzyme Immunoassay for the Rapid Detection of Osteocalcin in Human Serum Alexandra M. Crăciun, 1 Cees Vermeer,
More informationImmunoassays. EIA & RIA Product Portfolio. Commitment to innovation
Immunoassays EIA & RIA Portfolio Commitment to innovation info@idsplc.com www.idsplc.com Expertise in Endocrinology Diagnostics Immunodiagnostic Systems Limited is a leading in vitro diagnostic solutions
More informationEffects of Anti RANK ligand Denosumab on Beta Thalassemia induced osteoporosis
Effects of Anti RANK ligand Denosumab on Beta Thalassemia induced osteoporosis Mohamed Yassin 1 Ashraf T. Soliman2, Mohamed O. Abdelrahman3, Vincenzo De Sanctis 4 Departments of, 1 Hematology 2Pediatric
More informationCalcium Nephrolithiasis and Bone Health. Noah S. Schenkman, MD
Calcium Nephrolithiasis and Bone Health Noah S. Schenkman, MD Associate Professor of Urology and Residency Program Director, University of Virginia Health System; Charlottesville, Virginia Objectives:
More informationBMD: A Continuum of Risk WHO Bone Density Criteria
Pathogenesis of Osteoporosis Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis AGING MENOPAUSE OTHER RISK FACTORS RESORPTION > FORMATION Bone Loss LOW PEAK BONE MASS Steven T Harris
More informationHigh Dietary Sodium Intake Assessed by 24-hour Urine Specimen Increase Urinary Calcium Excretion and Bone Resorption Marker
J Bone Metab 214;21:189-194 http://dx.doi.org/1.115/jbm.214.21.3.189 pissn 2287-6375 eissn 2287-729 Original Article High Dietary Sodium Intake Assessed by 24-hour Urine Specimen Increase Urinary Calcium
More informationSkeletal. Parathyroid hormone-related protein Analyte Information
Skeletal Parathyroid hormone-related protein Analyte Information 1 2012-04-04 Parathyroid hormone related protein (PTHrP) Introduction Parathyroid hormone-related protein (PTHrP) is actually a family of
More informationCollagen Crosslinks, Any Method
190.19 - Collagen Crosslinks, Any Method Collagen crosslinks, part of the matrix of bone upon which bone mineral is deposited, are biochemical markers the excretion of which provides a quantitative measurement
More informationFRUIT AND VEGETABLE INTAKE IN POSTMENOPAUSAL WOMEN WITH OSTEOPENIA
FRUIT AND VEGETABLE INTAKE IN POSTMENOPAUSAL WOMEN WITH OSTEOPENIA Samira Ebrahimof, Anahita Hoshyarrad, Arash Hossein-Nezhad Nahid Zandi, Bagher Larijani, Masoud Kimiagar Abstract INTRODUCTION: Adequate
More informationESPEN Congress Prague 2007
ESPEN Congress Prague 2007 Key papers in the field of nutrition Dietitian Geila S Rozen Key Papers in the field of Nutrition ESPEN 2007 Prague Geila S Rozen Clinical Nutrition Dep. Rambam health campus
More informationThis review examines the dynamics of parathyroid hormone
In-Depth Review Dynamics of Parathyroid Hormone Secretion in Health and Secondary Hyperparathyroidism Arnold J. Felsenfeld,* Mariano Rodríguez, and Escolástico Aguilera-Tejero *Department of Medicine,
More informationMarker of Bone Resorption in Acute Response to Exogenous or Endogenous Parathyroid Hormone
ORIGINAL RESEARCH Marker of Bone Resorption in Acute Response to Exogenous or Endogenous Parathyroid Hormone Vit Zikan and Jan J. Stepan 3rd Department of Internal Medicine and Institute of Rheumatology,
More informationBone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated with High Bone Turnover
Medical Policy Manual Laboratory, Policy No. 23 Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated with High Bone Turnover Next Review: June 2018 Last Review: July
More informationOne Day Hormone Check
One Day Hormone Check DOB: Sex: F MRN: Order Number: Completed: Received: Collected: Salivary Hormone Results Estradiol pmol/l >3330.0 Testosterone pmol/l
More informationAn enzyme immunoassay for the quantitation pyridinium crosslinks in human urine SUMMARY. MicroVue PYD EIA Page 1 of 13
An enzyme immunoassay for the quantitation pyridinium crosslinks in human urine SUMMARY MicroVue PYD EIA Page 1 of 13 INTENDED USE MicroVue PYD is a urinary assay that provides a quantitative measure of
More informationSkeletal Manifestations
Skeletal Manifestations of Metabolic Bone Disease Mishaela R. Rubin, MD February 21, 2008 The Three Ages of Women Gustav Klimt 1905 1 Lecture Outline Osteoporosis epidemiology diagnosis secondary causes
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): July 10, 2002 Most Recent Review Date (Revised): July 22, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationORIGINAL ARTICLE SERUM OSTEOCALCIN, SHALL WE CONSIDER IT AS A BIOCHEMICAL MARKER FOR OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
SERUM OSTEOCALCIN, SHALL WE CONSIDER IT AS A BIOCHEMICAL MARKER FOR OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN V. S. Kalai Selvi 1, K. Prabhu 2, Monika Gupta 3. HOW TO CITE THIS ARTICLE: V. S. Kalai Selvi, K.
More informationChapter-IV. Blood pressure and heart rate variability as function of ovarian cycle in young women
Blood pressure and heart rate variability as function of ovarian cycle in young women INTRODUCTION In human females, the menstrual cycle begins with the onset of menstrual flow on day 1. The menstrual
More informationAssociations Between Liver Function, Bone Turnover Biomarkers and Adipokines in Older Patients With Hip Fracture
Elmer ress Original Article J Endocrinol Metab. 2014;4(5-6):121-135 Associations Between Liver Function, Bone Turnover Biomarkers and Adipokines in Older Patients With Hip Fracture Leon Fisher a, d, Alexander
More informationBone Mineral Density and Its Associated Factors in Naresuan University Staff
Naresuan University Journal 2005; 13(3): 13-18 13 Bone Mineral Density and Its Associated Factors in Naresuan University Staff Supawitoo Sookpeng *, Patsuree Cheebsumon, Malinee Dhanarun, Thanyavee Pengpan
More informationRelationship between bone resorption and adrenal sex steroids and their derivatives in oophorectomized women
FERTILITY AND STERILITY VOL. 82, NO. 6, DECEMBER 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Relationship between bone
More informationImportant aspects of acid-base disorders
Important aspects of acid-base disorders I. David Weiner, M.D. Co-holder, C. Craig and Audrae Tisher Chair in Nephrology Division of Nephrology, Hypertension and Transplantation University of Florida College
More informationCOURSE OUTLINE - Module I
Module I MEDICAL DISCLAIMER The information in this program is for educational purposes only. It is meant to as a guide towards health and does not replace the evaluation by and advice of a qualified licensed
More informationMeasurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases
British Journal of Cancer (1999) 8(8), 1265 127 Article no. bjoc.1999.496 Measurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases J Walls
More informationHYPERCALCEMIA. Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra hospital, Isfahan university of medical sciences
HYPERCALCEMIA Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra hospital, Isfahan university of medical sciences ESSENTIALS OF DIAGNOSIS Serum calcium level > 10.5 mg/dl Serum ionized
More informationGenetic examination of diseases affecting bone development. and structure in newborns
Genetic examination of diseases affecting bone development and structure in newborns Examination of molecular genetic markers in osteopenic preterm infants PhD Thesis Simone Funke, MD University of Pécs
More informationAn enzyme immunoassay for the quantitation of deoxypyridinoline (DPD) crosslinks in human urine SUMMARY. MicroVue DPD EIA Page 1 of 16
An enzyme immunoassay for the quantitation of deoxypyridinoline (DPD) crosslinks in human urine SUMMARY MicroVue DPD EIA Page 1 of 16 INTENDED USE MicroVue DPD EIA is a urinary assay that provides a quantitative
More informationN u r t u r e F o o d s
Tips on Timing of Diet, Weight Loss, and Exercise 1. Hydrate before you exercise to get the most out of your workout The goal here is to make sure your body has a balanced amount of electrolytes and fluid
More informationRenal System. Renal System. levels of organization. structure - function. homeostatic regulation
Renal System The goal of these lectures is to discuss basic renal physiology. This lecture will present the regulation of H and Ca ions as well as discuss the hormonal and neural regulation of renal function.
More informationProgesterone / Oestradiol Balance
Progesterone / Oestradiol Balance Patient Details Practitioner Details Genova Diagnostics ( Europe ) Ms Sample Report Client ID No: Patients DOB: Sample Date: Date Of Report: IWX500220 02/03/1965 Progesterone
More informationThe Parathyroid Glands Secrete Parathyroid Hormone, which Regulates Calcium, Magnesium, and Phosphate Ion Levels
17.6 The Parathyroid Glands Secrete Parathyroid Hormone, which Regulates Calcium, Magnesium, and Phosphate Ion Levels Partially embedded in the posterior surface of the lateral lobes of the thyroid gland
More informationThe effect of dietary sodium on calcium metabolism in premenopausal and postmenopausal women
European Journal of Clinical Nutrition (1997) 51, 394±399 ß 1997 Stockton Press. All rights reserved 0954±3007/97 $12.00 in premenopausal and postmenopausal women CEL Evans, AY Chughtai, A Blumsohn, M
More informationEffect of Ramadan fasting in Saudi Arabia on serum bone profile and immunoglobulins
594527TAE0010.1177/2042018815594527Therapeutic Advances in Endocrinology and MetabolismSM Bahijri, GM Ajabnoor research-article2015 Therapeutic Advances in Endocrinology and Metabolism Original Research
More informationDaclizumab improves asthma control in patients with moderate to. severe persistent asthma: A randomized, controlled trial
Daclizumab improves asthma control in patients with moderate to severe persistent asthma: A randomized, controlled trial William W. Busse, MD, Elliot Israel, MD, Harold S. Nelson, MD, James W. Baker, MD,
More informationUrinary Calculus Disease. Urinary Stones: Simplified Metabolic Evaluation. Urinary Calculus Disease. Urinary Calculus Disease 2/8/2008
Urinary Stones: Simplified Metabolic Evaluation Marshall L. Stoller, M.D. Professor and Vice Chairman Department of Urology University of California San Francisco Incidence: 7-21/10,000 3 men: 1 woman
More informationTrebeculae. Step 4. compact bone. Diploë Pearson Education, Inc.
Trebeculae compact bone Step 4 Diploë Abnormalities in bone growth Fibrodysplasia ossificans progressiva (FOP) autosomal dominant, Codon 206: Arg à Hist 1 : 2, 000, 000 endothelial cells à mesenchymal
More informationWHAT KEEPS OUR BONES STRONG?
WHAT KEEPS OUR BONES STRONG? The role of diet and lifestyle in osteoporosis prevention Thomas Walczyk PhD, Associate Professor Food Science and Technology Programme Department of Chemistry, Faculty of
More informationfor Medical Research. (Received May 10th, 1922.)
XLV. NOTE ON URINARY TIDES AND EXCRETORY RHYTHM. BY JAMES ARGYLL CAMPBELL AND THOMAS ARTHUR WEBSTER. From the Department of Applied Physiology, National Institute for Medical Research. (Received May 10th,
More informationantiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients
British Journal of Cancer (1998) 78(2), 240245 1998 Cancer Research Campaign Aminoterminal propeptide of type procollagen (PNP) correlates to bone loss and predicts the efficacy of antiresorptive therapy
More informationDisclosure and Conflicts of Interest Steven T Harris MD Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis
Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis Steven T Harris MD FACP Clinical Professor of Medicine University of California, San Francisco Disclosure and Conflicts of Interest
More informationApproach to a patient with hypercalcemia
Approach to a patient with hypercalcemia Ana-Maria Chindris, MD Division of Endocrinology Mayo Clinic Florida 2013 MFMER slide-1 Background Hypercalcemia is a problem frequently encountered in clinical
More informationReceived 1 March 2002; accepted for publication 28 July 2002
British Journal of Haematology, 2003, 120, 235 242 Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early
More informationPathophysiology of Postmenopausal & Glucocorticoid Induced Osteoporosis. March 15, 2016 Bone ECHO Kate T Queen, MD
Pathophysiology of Postmenopausal & Glucocorticoid Induced Osteoporosis March 15, 2016 Bone ECHO Kate T Queen, MD Review: normal bone formation Bone Modeling Remodeling Peak Bone Mass Maximum bone mass
More informationOsteoporosis. When we talk about osteoporosis, we have to be familiar with the constituents of bone and what it is formed of.
Osteoporosis When we talk about osteoporosis, we have to be familiar with the constituents of bone and what it is formed of. Osteoblasts by definition are those cells present in the bone and are involved
More informationCoordinator of Post Professional Programs Texas Woman's University 1
OSTEOPOROSIS Update 2007-2008 April 26, 2008 How much of our BMD is under our control (vs. genetics)? 1 2 Genetic effects on bone loss: longitudinal twin study (Makovey, 2007) Peak BMD is under genetic
More informationParathyroid hormone (serum, plasma)
Parathyroid hormone (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Parathyroid hormone (PTH) 1.2 Alternative names Parathormone 1.3 NMLC code 1.4 Description of analyte PTH is an
More informationAnatomy and Physiology. The Endocrine System
Anatomy and Physiology The Endocrine System The endocrine system includes anything that secretes hormones directly into body fluids. Endocrine glands include: the thyroid, parathyroid, adrenal, kidney,
More informationUniversity of Groningen
University of Groningen Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol Jacobs, Johannes W. G.; de Nijs, Ron N. J.; Lems, Willem F.; Geusens, Piet P. M. M.; Laan, Roland
More informationAnnual Rheumatology & Therapeutics Review for Organizations & Societies
Annual Rheumatology & Therapeutics Review for Organizations & Societies Biochemical Markers of Bone Turnover: Definitions and Recommendations for Monitoring Therapy Learning Objectives for Biochemical
More informationSouthern Derbyshire Shared Care Pathology Guidelines. Primary Hyperparathyroidism
Southern Derbyshire Shared Care Pathology Guidelines Primary Hyperparathyroidism Please use this Guideline in Conjunction with the Hypercalcaemia Guideline Definition Driven by hyperfunction of one or
More informationThe Clinical Use of Bone Resorption Markers in Patients with Malignant Bone Disease
2521 The Clinical Use of Bone Resorption Markers in Patients with Malignant Bone Disease Robert E. Coleman, M.D. Cancer Research Centre, YCR Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield,
More informationRhythm Plus- Comprehensive Female Hormone Profile
Rhythm Plus- Comprehensive Female Hormone Profile Patient: SAMPLE REPORT DOB: Sex: F Order Number: K00000 Completed: Received: Collected: SAMPLE REPORT Sample # Progesterone (pg/ml) Hormone Results Oestradiol
More informationPOSTMENOPAUSAL BONE LOSS poses a significant
0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(6):3528 3533 Printed in U.S.A. Copyright 2005 by The Endocrine Society doi: 10.1210/jc.2004-2451 Effects of Potassium Alkali
More informationResearch Article Study of Serum Calcium, Magnesium And Phosphorous Levels In Patients With Thyroid Disorders
Research Article Study of Serum Calcium, Magnesium And Phosphorous Levels In Patients With Thyroid Disorders Dr. Shweta R. Hebbar*, Dr. Nagarajappa. K., Dr. Sushma B. J, Dr. C. R. Mallikarjun Department
More informationDrugs Affecting Bone. Rosa McCarty PhD. Department of Pharmacology & Therapeutics
Drugs Affecting Bone Rosa McCarty PhD Department of Pharmacology & Therapeutics rmccarty@unimelb.edu.au Objectives At the end of this lecture you should have gained: An understanding of bone metabolism
More informationThe principal functions of the kidneys
Renal physiology The principal functions of the kidneys Formation and excretion of urine Excretion of waste products, drugs, and toxins Regulation of body water and mineral content of the body Maintenance
More informationEndocrine System. Endocrine vs. Exocrine. Bio 250 Human Anatomy & Physiology
Endocrine System Bio 250 Human Anatomy & Physiology Endocrine vs. Exocrine Endocrine glands secrete their products called hormones into body fluids (the internal environment) Exocrine glands secrete their
More informationDepartment of Internal Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical College, Tokyo 162, Japan
Endocrine Journal 1996, 43(6), 701-708 Carboxy-Terminal Propeptide of Type 1 Procollagen (P1 CP) and Carboxy-Terminal Telopeptide of Type 1 Collagen (1 CTP) as Sensitive Markers of Bone Metabolism in Thyroid
More information